How Cleerly and HeartFlow are hunting a massive, but still elusive killer – heart disease

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.

There are no comments yet.

Please log in to write the first comment.